Robert W. Postma - 03 Jul 2025 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Jul 2025, 19:11:39 UTC
Prior SEC filing
26 Jun 2025
Next SEC filing
26 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Melinda Lackey, Attorney-in-Fact

Key filing fact

Robert W. Postma filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 07 Jul 2025.

Key facts

  • This page summarizes Robert W. Postma's Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 07 Jul 2025, 19:11.

Change

  • Previous filing in this sequence was filed on 26 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001827847 Primary reporting owner

Postma Robert W

Relationship
Director
Address
C/O ALAUNOS THERAPEUTICS, INC., 2617 BISSONNET ST, SUITE 233, HOUSTON
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Signature date
07 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TCRT transaction

Common Stock

Award

Transaction value
$0
Shares
+4,050
Change %
+14%
Price
$0.000000
Shares after
33,133
Date
03 Jul 2025
Ownership
Direct
Footnotes
F1
TCRT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
24
Date
03 Jul 2025
Ownership
By spouse's IRA
TCRT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
62,416
Date
03 Jul 2025
Ownership
By WaterMill Asset Management Corp.
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TCRT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+6,400
Change %
Price
$0.000000
Shares after
6,400
Date
03 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,400
Exercise price
$5.00
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a grant of restricted stock units (RSUs) which immediately vested upon grant. After the reported acquisition of the RSUs, the reporting person owned in aggregate 33,133 shares of common stock (29,083 previously owned shares, plus the instant grant of 4,034 RSUs).

Footnote F2

The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.

Footnote F3

One-twelfth of the Option vests each month on the monthly anniversary of July 3, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .